Article preview from "The Pink Sheet" DAILY July 21, 2009
The House health care reform bill contains a number of provisions that would greatly expand the market for pharmaceuticals, but the bill seeks a number of financial concessions from pharmaceutical manufacturers, prompting a statement of protest from the industry association.
The House introduced its complete "America's Affordable Health Choices Act," H.R. 3200, on July 14, and the three committees of jurisdiction - Ways and Means, Energy and Commerce, and Education and Labor - began marking it up within the next two days. Read on...
Article preview from "The Pink Sheet" DAILY July 21, 2009
The bill would expand the market for pharmaceuticals in a number of ways, including:
1) Mandating coverage for all Americans and requiring that the core benefits of all plans include prescription drug covering.
2) Expanding the Medicaid program to include everyone up to 133 percent of the federal poverty level, with the federal government picking up the tab for the extra coverage.
3) Phasing out the coverage gap in the Medicare Part D prescription drug program over 15 years, starting with a reduction in the size of the donut hole to only $500 in 2011.
Purchase this article or sign-up for a free trial to "The Pink Sheet" DAILY today by clicking here!
